搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
ENDPOINTS NEWS
8 小时
Editas to cut 65% of workforce, officially stops work on ex vivo sickle ...
Editas Medicine will eliminate about 180 roles after failing to find a commercial partner for an experimental sickle cell ...
ENDPOINTS NEWS
18 小时
Handful of 'unsupported' drug price increases added $800M to US costs, ICER claims
ICER reports $800M+ annual US cost increase from 5 drugs (Biktarvy, Darzalex, Entresto, Cabometyx, Xeljanz) with 2023 price ...
ENDPOINTS NEWS
22 小时
Keros halts parts of Phase 2 PAH trial due to safety, stock tanks 70%
Keros Therapeutics halts two dosing arms of cibotercept Phase 2 trial due to pericardial effusion safety concerns; continues ...
ENDPOINTS NEWS
18 小时
Padlock shareholders sue Bristol Myers over milestone dispute after 2016 ac ...
Former Padlock shareholders sue Bristol Myers Squibb over alleged unpaid milestone payments for antibody BMS-986454, claiming ...
ENDPOINTS NEWS
16 小时
Pfizer shares positive Phase 3 results in breast cancer subset
Pfizer touts Ibrance’s status as a standard of care in HR-positive, HER2-negative metastatic breast cancer. Now the company ...
ENDPOINTS NEWS
19 小时
Inside Isomorphic Labs: Demis Hassabis’ lab-free vision for biotech’s AI fu ...
Demis Hassabis has no interest in a laboratory. The Nobel Prize-winning artificial intelligence pioneer is betting big on ...
ENDPOINTS NEWS
18 小时
Daiichi's $150M build in China; BioMarin reveals €60M Irish expansion
Daiichi Sankyo plans ADC facility in Shanghai, BioMarin expands in Cork, Vertex signs Saudi deal, EuroAPI CEO resigns, SK ...
ENDPOINTS NEWS
22 小时
Lonza looks to depart capsule and health ingredients as it undergoes re ...
Lonza CEO Wolfgang Wienand plans to exit capsules/health ingredients market and restructure into three business units, with ...
ENDPOINTS NEWS
20 小时
Recapping the Endpoints 100: The biotech industry braces itself for Trump 2.0
Endpoints News has once again reached out to a lengthy roster of biotech execs to take their pulse on what’s ahead for the ...
ENDPOINTS NEWS
18 小时
Eli Lilly and Ro’s unlikely relationship
Eli Lilly partners with telehealth company Ro to distribute discounted Zepbound vials at $399/month, while competitor Novo ...
ENDPOINTS NEWS
22 小时
Pleno raises $25M for multiomics testing, names new CEO
Illumina exec Vik Vaz as CEO to advance biological detection tech for drug research. The company uses what it calls ...
ENDPOINTS NEWS
22 小时
Corcept’s ALS drug fails to improve function in Phase 2 study
Corcept Therapeutics' dazucorilant fails Phase 2 ALS trial after missing primary endpoint, following October's Cushing's ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈